Single center retrospective study evaluating the impact of using the Quantra QPlus System to guide transfusion decisions on postoperative outcomes in patients undergoing cardiac surgery.
Yavapai Regional Medical Center (YRMC) implemented the Quantra QPlus System to aid in their efforts to effectively reduce the transfusion rate of allogenic blood products and improve outcomes in patients undergoing cardiac surgery. Use of the Quantra to guide decisions related to the use of blood products in cardiac surgery patients began in 2019. In this retrospective study, YRMC evaluated the impact of using the Quantra QPlus System to guide transfusion decisions on postoperative outcomes in patients undergoing cardiac surgery.
Study Type
OBSERVATIONAL
Enrollment
128
Coagulation monitoring system
Yavapai Regional Medical Center
Prescott, Arizona, United States
Blood product utilization
Units of blood products administered to patient
Time frame: Intraoperative - during surgery
Blood product utilization
Units of blood products administered to patient
Time frame: Postoperative - after surgery throughout the rest of the hospital stay, assessed up to 30 days
Cost of blood products
Total cost of blood products administered to patient
Time frame: Throughout the entire hospital stay, assessed up to 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.